David R. Pelizzon

David R. Pelizzon is a declared insider at 2 companies (board member); the most frequent names are Orthopediatrics Corp and Alphatec Holdings, Inc. Between 16 October 2017 and 10 September 2026, the trades on record add up to 46 filings.

In open-market terms, that means 14 purchases worth €76.6M on one side and 12 sales worth €31.1M on the other. The net balance comes to €45.6M on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 17 share grants and 1 option exercise. In 2026 alone, the filings show no purchases and 7 sales.

The median purchase comes to €50k. Of 14 purchases, 8 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 14 purchases show a median change of -1.9%, with the price up in 50% of them. Past outcomes like these are no guarantee of what comes next.

Most recently, on 10 September 2026, the filings show an open-market sale worth €5.5M in Orthopediatrics Corp. The most recent open-market purchase was published on 26 August 2024, 788 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.